PF-00299804

A drug used to treat non-small cell lung cancer that has spread to other parts of the body and has not already been treated. It is used in patients whose cancer has certain mutations (changes) in a gene called epidermal growth factor receptor (EGFR). It is also being studied in the treatment of other types of cancer. PF-00299804 blocks certain proteins made by the mutated EGFR gene, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called dacomitinib and Vizimpro.

• Dailymed label info on PF-00299804
• FDA PF-00299804

PF-00299804 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski